 SAN DIEGO, March 02, 2021 GLOBE NEWSWIRE -- Exagen Inc. Nasdaq: XGN, a leading autoimmune organization, will release financial results for the quarter and year ended December 31, 2020 after the market close on Tuesday, March 16, 2021. Ron Rocca, President and Chief Executive Officer, and Kamal Adawi, Chief Financial Officer, will host a conference call to review the Companys results at 4:30 PM Eastern Time 1:30 PM Pacific Time. 